Tumor recurrence and therapeutic resistance: exploring and exploiting the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors

Project Information

RESISTANCEPROGRAMS

Grant agreement ID: 101043587

DOI

10.3030/101043587

EC signature date 11 April 2022

Start date 1 September 2022

End date 31 August 2027

Funded under

• European Research Council (ERC)

Total cost

€ 1 999 444,00

EU contribution

€ 1 999 444,00

Coordinated by

LUNDS UNIVERSITET
Sweden

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

Data Management Plan

Publications

Peer reviewed articles (1)

Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment

Author(s): Rebecca Rosberg; Karolina I. Smolag; Jonas Sjölund; Elinn Johansson; Christina Bergelin; Julia Wahldén; Vasiliki Pantazopoulou; Crister Ceberg; Kristian Pietras; Anna M. Blom; Alexander Pietras
Published in: Crossref, 2024, ISSN 2379-3708
Publisher: American Society for Clinical Investigation (ASCI)
DOI: 10.1101/2024.01.28.577617